Supports Continued Research for the Development of Innovative 3D Printable, Biocompatible Advanced Materials, and Stem Cell Delivery Techniques for Traumatic Brain Injuries  NEW YORK, NY, Nov. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Qrons Inc. (QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment… Read More..

Company Continues to Execute on Improving Production Efficiencies, Processing Capabilities and Integrating Perry County Resources into American Resources' Existing Platform FISHERS, IN / ACCESSWIRE / November 7, 2019 /American Resources Corporation (NASDAQ:AREC) (the "Company"), a supplier of raw materials to the rapidly growing global infrastructure marketplace is pleased to provide… Read More..

DUBLIN, Ohio--(BUSINESS WIRE)-- Conference Call to be held Thursday, November 7, 2019 at 5:00 pm EDT Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the third quarter ended September 30,… Read More..